News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding The advantage of apixaban was consistent across a variety of subgroups and confirms earlier observations. L.A. McKeown May 16, 2025
Presentation ACC 2025 Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial Presenter: Darren K. McGuire March 29, 2025
Presentation ACC 2025 Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension Presenter: Luke Laffin March 29, 2025
Presentation ACC 2025 Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study Presenter: Keyvan Karkouti March 29, 2025
Presentation Controversies and Advances 2025 Future Interventions for the Heart & Other Organs: “The Internet of the Human Body” Presenter: Kalyanam Shivkumar January 30, 2025
Presentation Controversies and Advances 2025 Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net! Presenter: Richard J. Auchus January 30, 2025
News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding By L.A. McKeown May 16, 2025
News Conference News European Congress on Obesity 2025 Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity By Michael O'Riordan May 16, 2025
News Daily News Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring By Caitlin E. Cox May 15, 2025
News Conference News European Congress on Obesity 2025 Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery By Michael O'Riordan May 14, 2025
News Daily News CV Death Rates in Autoimmune Disorders Waning, but Still Higher in Women By L.A. McKeown May 14, 2025